期刊文献+

观察活血行气利水汤联合消胀散外敷治疗肝硬化腹水的可行性及有效性 被引量:1

To Observe the Feasibility and Effectiveness of Huoxue Xingqi Lishui Decoction combined with Xiaozhang Powder in the Treatment of Cirrhotic Ascites
下载PDF
导出
摘要 目的分析活血行气利水汤联合消胀散外敷治疗肝硬化腹水的可行性及有效性。方法在我院于2017年5月至2020年5月收治的肝硬化腹水患者中,选取30例作为本次的研究对象,其中15例采用西药治疗的患者纳入对照组,另外15例采用活血行气利水汤联合消胀散外敷治疗的患者纳入研究组,对比两组患者的治疗有效率、肝功能指标变化情况、临床症状体征改善情况、不良反应发生情况以及症状改善时间。结果研究组患者的治疗有效率高于对照组(P<0.05),不良反应发生率低于对照组(P<0.05);与治疗前相比,两组患者的肝功能指标均得到了明显改善,且研究组患者的肝功能指标优于对照组(P<0.05);与对照组相比,研究组患者的临床症状体征改善程度优于对照组(P<0.05);研究组患者的症状改善时间短于对照组(P<0.05)。结论对肝硬化腹水患者采用活血行气利水汤联合消胀散外敷治疗,能有效改善患者的肝功能指标,改善患者的临床症状体征,效果显著,并且不良反应少,用药安全性高。 Objective To analyze the feasibility and effectiveness of Huoxue Xingqi Lishui Decoction combined with Xiaozhang Powder in the treatment of ascites due to cirrhosis.Methods Among the patients with liver cirrhosis and ascites admitted in our hospital from May 2017 to May 2020,30 cases were selected as the research objects.Among them,15 cases treated with western medicine were included in the control group,and the other 15 cases treated with Huoxue Xingqi Lishui Decoction and external application of Xiaozhang Powder were included in the study group.The effective rate of treatment,changes in liver function indexes,improvement of clinical symptoms and signs,and occurrence of adverse reactions were compared between the two groups.Results The effective rate of treatment in the study group was higher than that in the control group (P<0.05),and the incidence of adverse reactions was lower than that in the control group (P<0.05).Compared with the conditions before the treatment,the liver function index of the two groups was significantly improved,and the liver function index of the study group was better than that of the control group (P<0.05).The clinical symptoms and signs of the study group were better than those of the control group (P<0.05).The symptom improvement time of the study group was shorter than that of the control group (P<0.05).Conclusion For patients with liver cirrhosis and ascites,Huoxue Xingqi Lishui Decoction combined with external application of Xiaozhang Powder can effectively improve the liver function indexes of the patients,and improve the clinical symptoms and signs of the patients.The effect is significant,and the adverse reactions are few.
作者 梁志海 LIANG Zhi-hai(People's Hospital of Qujiang District,Shaoguan City,Shaoguan,Guangdong 512100)
出处 《智慧健康》 2021年第4期164-166,169,共4页 Smart Healthcare
关键词 活血行气利水汤 消胀散外敷 肝硬化腹水 Huoxue Xingqi Lishui Decoction Xiaodao San external application Cirrhosis ascites
  • 相关文献

二级参考文献76

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2慢性乙型肝炎防治指南[J].临床肝胆病杂志,2006,22(1):3-15. 被引量:69
  • 3郑虎占 董泽宏 佘靖.中药现代研究与应用[M].北京:学苑出版社,1997.1497-1503,2138-2148,3694—3707.
  • 4中华人民共和国卫生部.涉及人的生物医学研究伦理审查办法(试行)[S].(2007-03-26)[2010-04-05].http://www.moh.gov.cn/qjjys/s3581/200804/b9f1bfee4ab344ec892e68097296e2a8.shtml.
  • 5裴正学.肝病的中西医结合治疗[M].兰州:甘肃科学技术出版社,2000:272.
  • 6谢渭芬.肝硬化腹水的诊断和治疗[A].中华医学会第七次全国消化病学术会议论文集[c].2007:761-764.
  • 7FANG W, LI H, ZHOU L, et al. Effect of prostaglandin E1 on TNF -induced vascular inflammation in human umbilical vein endothelial cells [ J ]. Can J Physiol Pharmacol, 2010, 88 ( 51 = 576 - 583.
  • 8CHUNG WG, KIM H J, CHOE YG, et al. Clinical impacts of haz- ardous alcohol use and obesity on the outcome of entecavir therapy in treatment -nafve patients with chronic hepatitis B in- fection[J]. Clin Mol Hepatol, 2012, 18(2). 195-202.
  • 9吴静.赤芍的药理研究及抗肝纤维化临床应用近况[J].中西医结合肝病杂志,2008,18(3):189-191. 被引量:18
  • 10彭福秀.中医为主治疗乙肝后肝硬化腹水的临床观察[J].中国民族民间医药,2010,19(10):183-184. 被引量:10

共引文献136

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部